Showing results (61-70 of 829) with videos related to
Sort By:
Pageof 83
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 30, 2009
Autoregulation of glomerular filtration rate during spironolactone treatment in hypertensive patients with type 1 diabetes: a randomized crossover trialKatrine J Schjoedt, Per K Christensen, Anders Jorsal, et al.The Journal of Clinical Endocrinology and Metabolism|June 6, 2015
IGFBP-4 Fragments as Markers of Cardiovascular Mortality in Type 1 Diabetes Patients With and Without NephropathyRikke Hjortebjerg, Lise Tarnow, Anders Jorsal, et al.Diabetes Care|January 31, 2006
Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathyAnne Sofie Astrup, Lise Tarnow, Peter Rossing, et al.Journal of Diabetes and Its Complications|August 14, 2012
Serum amyloid A and C-reactive protein levels may predict microalbuminuria and macroalbuminuria in newly diagnosed type 1 diabetic patientsAnne Julie Overgaard, James N McGuire, Peter Hovind, et al.Amino Acids|March 9, 2011
Effect of Irbesartan treatment on plasma and urinary markers of protein damage in patients with type 2 diabetes and microalbuminuriaNaila Rabbani, Antonysunil Adaikalakoteswari, Kasper Rossing, et al.Diabetologia|August 18, 2016
Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trialPeter Gæde, Jens Oellgaard, Bendix Carstensen, et al.The Journal of Clinical Endocrinology and Metabolism|May 29, 2008
Elevated levels of high-molecular-weight adiponectin in type 1 diabetesHenrik Leth, Kristian K Andersen, Jan Frystyk, et al.Diabetologia|November 5, 2017
Biomarkers of inflammation and endothelial dysfunction as predictors of pulse pressure and incident hypertension in type 1 diabetes: a 20 year life-course study in an inception cohortIsabel Ferreira, Peter Hovind, Casper G Schalkwijk, et al.Diabetes Care|April 30, 2003
Long-term renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?Steen Andersen, Lise Tarnow, Francois Cambien, et al.Kidney International|June 26, 2002
Renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?Steen Andersen, Lise Tarnow, Francois Cambien, et al.Pageof 83